Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis
Clinical trial NCT02704338 · UNKNOWN
Trial details
- NCT number
- NCT02704338
- Sponsor
- Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.